We prospectively analysed the potential usefulness of a symptom-limited wal
k test: the shuttle walk test (SWT), in the prediction of major cardiac eve
nts in 46 consecutive patients with chronic heart failure (NYHA class II-IV
, ejection fraction <0.40) and compared it with that of a time-limited walk
test, the six-minute walk test (6-MT). After a mean follow-up of 17 months
(range, 8-28 months), 15 of 46 patients (33%) experienced a major cardiac
event, defined as a cardiac death, urgent transplantation, or hospital admi
ssion for continuous inotropic or mechanical support. Distance walked in th
e SWT was shown to be a predictor of outcome at one year of follow-up (P=0.
03), but distance ambulated in the 6-MT was not (P=0.07). In multivariate a
nalysis, percentage of age-gender predicted peak oxygen uptake was the best
predictor of major cardiac events. When patients were divided into tertile
s according to performance in both walk tests, there was an overall differe
nce in event-free survival at 12 months among SWT tertiles (P=0.004), but n
ot among 6-MT tertiles (P=0.09). A low performance in the SWT (distance amb
ulated <450 m) allowed identification of a subgroup of patients with a high
risk for major cardiac events at short-term. We conclude that, in patients
with chronic heart failure, distance ambulated in the SWT predicts event-f
ree survival at one year better than that in the 6-MT. (C) 2000 Elsevier Sc
ience Ireland Ltd. All rights reserved.